Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 290, Issue 1, Pages 85-99
Publisher
Wiley
Online
2019-07-29
DOI
10.1111/imr.12793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and Lifespan
- (2019) Maria Streltsova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI
- (2019) Bridget A. Kennis et al. JOURNAL OF NEURO-ONCOLOGY
- Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
- (2019) Olaf Oberschmidt et al. Human Gene Therapy Methods
- Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
- (2019) SoonHo Kweon et al. Frontiers in Immunology
- Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia
- (2018) M. Vela et al. CANCER LETTERS
- Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome byEx Vivo–Expanded Autologous NK Cells
- (2018) Yufeng Wang et al. CLINICAL CANCER RESEARCH
- Umbilical cord blood-derived natural killer cells combined with Bevacizumab for colorectal cancer treatment
- (2018) Chen Xu et al. HUMAN GENE THERAPY
- Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
- (2018) Folashade Otegbeye et al. PLoS One
- Expanded CD56superbrightCD16+ NK cells from ovarian cancer patients are cytotoxic against autologous tumor in a patient-derived xenograft murine model
- (2018) Sophie M Poznanski et al. Cancer Immunology Research
- Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
- (2018) Meisam Naeimi Kararoudi et al. Jove-Journal of Visualized Experiments
- Real-Time Tracking of Ex Vivo-Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers
- (2018) Tung Nguyen Thanh Uong et al. Frontiers in Immunology
- Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells
- (2018) Jolie R. Schafer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of “senescent” NK cells to lose CD57 expression and start expressing NKG2A
- (2018) Maria A. Streltsova et al. PLoS One
- Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
- (2017) Stephan Klöß et al. HUMAN GENE THERAPY
- The Broad Spectrum of Human Natural Killer Cell Diversity
- (2017) Aharon G. Freud et al. IMMUNITY
- Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21
- (2017) Maria A. Streltsova et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells
- (2017) Sophie M. Poznanski et al. Journal of Innate Immunity
- Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
- (2017) Xingchun Gao et al. Frontiers in Immunology
- A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
- (2017) Juliane Wagner et al. Frontiers in Immunology
- Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma
- (2017) Alexander A. Tong et al. OncoImmunology
- Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
- (2017) Yaya Chu et al. OncoImmunology
- Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
- (2017) Robert J. Canter et al. Journal for ImmunoTherapy of Cancer
- Interleukin-21 administration leads to enhanced antigen-specific T cell responses and natural killer cells in HIV-1 vaccinated mice
- (2016) Bin Ju et al. CELLULAR IMMUNOLOGY
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34 + cells
- (2016) Anna Domogala et al. CYTOTHERAPY
- T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
- (2016) Aude G. Chapuis et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
- (2016) Aude G. Chapuis et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Repression of GSK3 restores NK cell cytotoxicity in AML patients
- (2016) Reshmi Parameswaran et al. Nature Communications
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
- (2016) Jennifer A. Foltz et al. Frontiers in Immunology
- Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
- (2016) Alejandra Leivas et al. OncoImmunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
- (2015) Jeremiah L. Oyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D–NKG2DL dependent manner
- (2015) L. Fernández et al. CANCER LETTERS
- Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
- (2015) XIAOMEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Interleukin-21 induces proliferation and modulates receptor expression and effector function in canine natural killer cells
- (2015) Dong-Jun Shin et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion
- (2015) Bharat K. R. Chaganty et al. OncoImmunology
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
- (2014) N. N. Shah et al. BLOOD
- Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation
- (2014) S. Zhu et al. BLOOD
- Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells
- (2014) G. Romain et al. BLOOD
- Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21
- (2014) Bo Jiang et al. CELLULAR IMMUNOLOGY
- KIR3DL01 Recognition of Bw4 Ligands in the Rhesus Macaque: Maintenance of Bw4 Specificity since the Divergence of Apes and Old World Monkeys
- (2014) J. L. Schafer et al. JOURNAL OF IMMUNOLOGY
- Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells
- (2014) F Fei et al. LEUKEMIA
- Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis
- (2014) Sergei R. Guma et al. PEDIATRIC BLOOD & CANCER
- Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
- (2014) Y. Chu et al. Cancer Immunology Research
- Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
- (2013) Yibing Xu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- A new approach to gene therapy usingSleeping Beautyto genetically modify clinical-grade T cells to target CD19
- (2013) Harjeet Singh et al. IMMUNOLOGICAL REVIEWS
- Membrane-bound TRAIL Supplements Natural Killer Cell Cytotoxicity Against Neuroblastoma Cells
- (2013) Michael A. Sheard et al. JOURNAL OF IMMUNOTHERAPY
- Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions
- (2013) Lisa M. Kopp et al. MOLECULAR IMMUNOLOGY
- Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis
- (2013) Sergei R. Guma et al. PEDIATRIC BLOOD & CANCER
- The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells
- (2013) Shiguo Zhu et al. PHARMACEUTICAL RESEARCH
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Membrane-bound interleukin-21 and CD137 ligand induce functional human natural killer cells from peripheral blood mononuclear cells through STAT-3 activation
- (2012) X. Wang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies
- (2012) Noriko Shimasaki et al. CYTOTHERAPY
- Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers
- (2012) Maja Todorovic et al. JOURNAL OF IMMUNOTHERAPY
- Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity
- (2012) Anastasia Shibina et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
- (2011) Ginna G. Laport et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism
- (2011) E. Nitta et al. BLOOD
- Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
- (2011) Emilie P. Buddingh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
- (2011) H. Singh et al. CANCER RESEARCH
- Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function
- (2011) Prakash Satwani et al. CYTOTHERAPY
- Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells
- (2011) Hua Zhang et al. JOURNAL OF IMMUNOTHERAPY
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
- (2011) Srinivas S. Somanchi et al. Jove-Journal of Visualized Experiments
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
- (2010) Uwe Siegler et al. CYTOTHERAPY
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
- (2010) Tolga Sutlu et al. CYTOTHERAPY
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression
- (2010) Véronique Decot et al. EXPERIMENTAL HEMATOLOGY
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- The Interactions of Multiple Cytokines Control NK Cell Maturation
- (2010) J. Brady et al. JOURNAL OF IMMUNOLOGY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15
- (2010) W. Gong et al. TISSUE ANTIGENS
- IL-15R -IgG1-Fc Enhances IL-2 and IL-15 Anti-tumor Action through NK and CD8+ T Cells Proliferation and Activation
- (2010) Z. Wu et al. Journal of Molecular Cell Biology
- Replicative potential of human natural killer cells
- (2009) Hiroyuki Fujisaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
- (2009) F. Reim et al. CANCER RESEARCH
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?
- (2009) Jeffrey S. Miller CYTOTHERAPY
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Safety analysis ofex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
- (2009) Lisbeth Barkholt et al. Immunotherapy
- Endogenous IL-21 Restricts CD8+ T Cell Expansion and Is not Required for Tumor Immunity
- (2009) H. Sondergaard et al. JOURNAL OF IMMUNOLOGY
- In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy
- (2009) J. Tomala et al. JOURNAL OF IMMUNOLOGY
- Natural killer cell-based immunotherapy in cancer: current insights and future prospects
- (2009) T. Sutlu et al. JOURNAL OF INTERNAL MEDICINE
- Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy
- (2009) Duck Cho et al. Korean Journal of Laboratory Medicine
- Umbilical Cord Mesenchymal Stem Cells Increase Expansion of Cord Blood Natural Killer Cells
- (2008) Laurent Boissel et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
- (2008) E. Alici et al. BLOOD
- Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
- (2008) Jumei Shi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation
- (2008) Sandrine Meyer-Monard et al. TRANSFUSION
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now